{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T19:52:01Z","timestamp":1768420321376,"version":"3.49.0"},"reference-count":52,"publisher":"BMJ","issue":"10","funder":[{"DOI":"10.13039\/501100000028","name":"Institute of Circulatory and Respiratory Health","doi-asserted-by":"publisher","award":["RN260949 - 342593"],"award-info":[{"award-number":["RN260949 - 342593"]}],"id":[{"id":"10.13039\/501100000028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2016,9,15]]},"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>In patients with transient thrombocytopenia being treated with high-dose chemotherapy followed by stem cell rescue\u2014haematopoietic stem cell transplantation (HSCT), prophylactic transfusions are standard therapy to prevent bleeding. However, a recent multicentre trial suggests that prophylactic platelet transfusions in HSCT may not be necessary. Additionally, the potential overuse of platelet products places a burden on a scarce healthcare resource. Moreover, the benefit of prophylactic platelet transfusions to prevent clinically relevant haemorrhage is debatable. Current randomised data compare different thresholds for administering prophylactic platelets or prophylactic versus therapeutic platelet transfusions. An alternative strategy involves prescribing prophylactic antifibrinolytic agents such as tranexamic acid to prevent bleeding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This report describes the design of an open-labelled randomised pilot study comparing the prophylactic use of oral tranexamic acid with platelet transfusions in the setting of autologous HSCT. In 3\u20135 centres, 100 patients undergoing autologous HSCT will be randomly assigned to either a prophylactic tranexamic acid or prophylactic platelets bleeding prevention strategy-based daily platelet values up to 30\u2005days post-transplant. The study will be stratified by centre and type of transplant. The primary goal is to demonstrate study feasibility while collecting clinical outcomes on (1) WHO and Bleeding Severity Measurement Scale (BSMS), (2) transplant-related mortality, (3) quality of life, (4) length of hospital stay, (5) intensive care unit admission rates, (6) Bearman toxicity scores, (7) incidence of infections, (8) transfusion requirements, (9) adverse reactions and (10) economic analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>\n                      This study is funded by a peer-reviewed grant from the Canadian Institutes of Health Research (201\u2005503) and is registered on Clinicaltrials.gov\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT02650791\">NCT02650791<\/jats:ext-link>\n                      . It has been approved by the Ottawa Health Science Network Research Ethics Board. Study results will presented at national and international conferences. Importantly, the results of this trial will inform the feasibility and conduct of a larger study.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02650791?term=PATH+platelet&amp;rank=1\" ext-link-type=\"uri\">NCT02650791<\/jats:ext-link>\n                      ; Pre-results.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2016-013483","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T21:28:49Z","timestamp":1477344529000},"page":"e013483","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot study"],"prefix":"10.1136","volume":"6","clinical-trial-number":[{"clinical-trial-number":"nct02650791","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02650791","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"isrctn50867461","registry":"10.18810\/isrctn"}],"author":[{"given":"Jason","family":"Tay","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Allan","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Beattie","sequence":"additional","affiliation":[{"name":"Department of Psychosocial Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Bredeson","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Fergusson","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn","family":"Maze","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Toronto"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell","family":"Sabloff","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kednapa","family":"Thavorn","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Tinmouth","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2016,10,24]]},"reference":[{"key":"2025120618060935000_6.10.e013483.1","doi-asserted-by":"crossref","unstructured":"Estcourt L , Stanworth S , Doree C , et al . Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev 2012;(5):CD004269. doi:10.1002\/14651858.CD004269.pub3","DOI":"10.1002\/14651858.CD004269.pub3"},{"key":"2025120618060935000_6.10.e013483.2","doi-asserted-by":"publisher","DOI":"10.7326\/M14-1589"},{"key":"2025120618060935000_6.10.e013483.3","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/trf.12943","article-title":"Platelet transfusion: a systematic review of the clinical evidence","volume":"55","author":"Kumar","year":"2015","journal-title":"Transfusion"},{"key":"2025120618060935000_6.10.e013483.4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.tmrv.2014.11.004","article-title":"Guidance on platelet transfusion for patients with hypoproliferative thrombocytopenia","volume":"29","author":"Nahirniak","year":"2015","journal-title":"Transfus Med Rev"},{"key":"2025120618060935000_6.10.e013483.5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/trf.12817","article-title":"Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation","volume":"55","author":"Christou","year":"2015","journal-title":"Transfusion"},{"key":"2025120618060935000_6.10.e013483.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1212772"},{"key":"2025120618060935000_6.10.e013483.7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705246"},{"key":"2025120618060935000_6.10.e013483.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60689-8"},{"key":"2025120618060935000_6.10.e013483.9","unstructured":"Callum JL , Lin Y , Pinkerton PH , et al . Bloody easy 3: blood transfusions, blood alternatives and transfusion reactions, a guide to transfusion medicine. 3rd edn. Orbcon, 2011."},{"key":"2025120618060935000_6.10.e013483.10","unstructured":"Galel SA . Infectious disease screening AABB technical manual. 18th edn. 2014:179\u2013206."},{"key":"2025120618060935000_6.10.e013483.11","unstructured":"Lin Y , Callum JL , Pinkerton PH . Adverse reactions. 2011 edn. Clinical Guide To Transfusion, 2013."},{"key":"2025120618060935000_6.10.e013483.12","unstructured":"Mazzei CA , Popovsky M , Kopko PM . Noninfectious complications of blood transfusion. In: Fung MK , Grossman BJ , Hillyer C , Westhoff CM , eds. Technical Manual, 18th edition, 2014:665\u201392. http:\/\/marketplace.aabb.org\/EbusPPROD\/Default.aspx?TabID=55&productId=2042730"},{"key":"2025120618060935000_6.10.e013483.13","doi-asserted-by":"crossref","unstructured":"Wardrop D , Estcourt LJ , Brunskill SJ , et al . Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders. Cochrane Database Syst Rev 2013;(7):CD009733. doi:10.1002\/14651858.CD009733.pub2","DOI":"10.1002\/14651858.CD009733.pub2"},{"key":"2025120618060935000_6.10.e013483.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90181-5"},{"key":"2025120618060935000_6.10.e013483.15","doi-asserted-by":"publisher","DOI":"10.3109\/10428199509059668"},{"key":"2025120618060935000_6.10.e013483.16","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1111\/trf.12646","article-title":"Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial","volume":"54","author":"Stanworth","year":"2014","journal-title":"Transfusion"},{"key":"2025120618060935000_6.10.e013483.17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-178236"},{"key":"2025120618060935000_6.10.e013483.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904084"},{"key":"2025120618060935000_6.10.e013483.19","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/j.0041-1132.2004.04118.x","article-title":"Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design","volume":"44","author":"Tinmouth","year":"2004","journal-title":"Transfusion"},{"key":"2025120618060935000_6.10.e013483.20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-05-1841"},{"key":"2025120618060935000_6.10.e013483.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196205032661802"},{"key":"2025120618060935000_6.10.e013483.22","doi-asserted-by":"publisher","DOI":"10.1053\/tmrv.2002.29403"},{"key":"2025120618060935000_6.10.e013483.23","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1182\/blood.V91.9.3509","article-title":"A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation","volume":"91","author":"Bernstein","year":"1998","journal-title":"Blood"},{"key":"2025120618060935000_6.10.e013483.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05769.x"},{"key":"2025120618060935000_6.10.e013483.25","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1200\/JCO.2001.19.5.1519","article-title":"Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology","volume":"19","author":"Schiffer","year":"2001","journal-title":"J Clin Oncol"},{"key":"2025120618060935000_6.10.e013483.26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1537-2995.1974.tb04558.x","article-title":"The prophylactic treatment of thrombocytopenic leukemic patients with platelets: a double blind study","volume":"14","author":"Higby","year":"1974","journal-title":"Transfusion"},{"key":"2025120618060935000_6.10.e013483.27","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830120406"},{"key":"2025120618060935000_6.10.e013483.28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0140-6736(78)90505-6","article-title":"Platelet prophylaxis in acute non-lymphoblastic leukaemia","volume":"1","author":"Solomon","year":"1978","journal-title":"Lancet"},{"key":"2025120618060935000_6.10.e013483.29","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404920"},{"key":"2025120618060935000_6.10.e013483.30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.joms.2014.07.033","article-title":"Effect of tranexamic acid irrigation on perioperative blood loss during orthognathic surgery: a double-blind, randomized controlled clinical trial","volume":"73","author":"Eftekharian","year":"2015","journal-title":"J Oral Maxillofac Surg"},{"key":"2025120618060935000_6.10.e013483.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.knee.2014.12.002"},{"key":"2025120618060935000_6.10.e013483.32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/ajo.12262","article-title":"The effect of prophylactic intravenous tranexamic acid on blood loss after vaginal delivery in women at low risk of postpartum haemorrhage: a double-blind randomised controlled trial","volume":"55","author":"Mirghafourvand","year":"2015","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2025120618060935000_6.10.e013483.33","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1745-6215-15-450","article-title":"HALT-IT\u2014tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial","volume":"15","author":"Roberts","year":"2014","journal-title":"Trials"},{"key":"2025120618060935000_6.10.e013483.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.11.007"},{"key":"2025120618060935000_6.10.e013483.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2014.09.023"},{"key":"2025120618060935000_6.10.e013483.36","unstructured":"National Heart Lung and Blood Institute. The diagnosis, evaluation, and management of von Willebrand disease. NIH publication no 08-5832. Bethesda, MD: U.S. Dept. of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, 2007."},{"key":"2025120618060935000_6.10.e013483.37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2012.02909.x"},{"key":"2025120618060935000_6.10.e013483.38","unstructured":"World Health Organization. WHO handbook for reporting results of cancer treatment. Geneva: World Health Organization, 1979."},{"key":"2025120618060935000_6.10.e013483.39","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2012.1.157"},{"key":"2025120618060935000_6.10.e013483.40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.03153.x"},{"key":"2025120618060935000_6.10.e013483.41","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12058"},{"key":"2025120618060935000_6.10.e013483.42","first-page":"1530","article-title":"The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia","volume":"91","author":"Webert","year":"2006","journal-title":"Haematologica"},{"key":"2025120618060935000_6.10.e013483.43","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1111\/j.1537-2995.2012.03634.x","article-title":"A new tool to assess bleeding severity in patients with chemotherapy-induced thrombocytopenia","volume":"52","author":"Webert","year":"2012","journal-title":"Transfusion"},{"key":"2025120618060935000_6.10.e013483.44","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/trf.12441","article-title":"Does bleeding affect patient-reported outcome measures in patients with myelodysplasia or hematologic malignancies: a systematic review","volume":"54","author":"Estcourt","year":"2014","journal-title":"Transfusion"},{"key":"2025120618060935000_6.10.e013483.45","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1537-2995.2010.02982.x","article-title":"Time to rethink clinically important outcomes in platelet transfusion trials","volume":"51","author":"Heddle","year":"2011","journal-title":"Transfusion"},{"key":"2025120618060935000_6.10.e013483.46","doi-asserted-by":"publisher","DOI":"10.3109\/07853890109002087"},{"key":"2025120618060935000_6.10.e013483.47","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-006-0102-1"},{"key":"2025120618060935000_6.10.e013483.48","unstructured":"Patient-Centered Outcomes Research Institute. 2015. http:\/\/www.pcori.org\/ (accessed 05 Nov 2015)."},{"key":"2025120618060935000_6.10.e013483.49","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","article-title":"Regimen-related toxicity in patients undergoing bone marrow transplantation","volume":"6","author":"Bearman","year":"1988","journal-title":"J Clin Oncol"},{"key":"2025120618060935000_6.10.e013483.50","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700672"},{"key":"2025120618060935000_6.10.e013483.51","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.10.1092"},{"key":"2025120618060935000_6.10.e013483.52","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1537-2995.2004.03231.x","article-title":"Methods for the analysis of bleeding outcomes in randomized trials of PLT transfusion triggers","volume":"44","author":"Cook","year":"2004","journal-title":"Transfusion"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2016-013483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T02:06:23Z","timestamp":1765073183000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2016-013483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":52,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10,24]]},"published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.1136\/bmjopen-2016-013483"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2016-013483","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}